Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
318.15
+9.99 (+3.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
37
38
Next >
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today
June 21, 2023
Via
Benzinga
Amgen's Debt Overview
June 20, 2023
Via
Benzinga
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million
June 15, 2023
Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.
Via
Investor's Business Daily
5 Stocks to Buy With Explosive 500% Potential
June 12, 2023
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.
Via
InvestorPlace
Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today
June 05, 2023
Via
Benzinga
Amgen Unusual Options Activity For June 01
June 01, 2023
Via
Benzinga
Why AbbVie and Amgen Are Moving Lower Today
June 01, 2023
An ultra-low-priced biosimilar may negatively impact both biotechs.
Via
The Motley Fool
Is Amgen a Good Dividend Stock?
June 01, 2023
The biotech's yield is near an all-time high right now.
Via
The Motley Fool
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
These elite drugmakers are both working through a number of headwinds.
Via
The Motley Fool
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
June 08, 2023
This year’s 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023) provided a surprising amount of clinical data relevant to biopharma investors.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
June 08, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
The 3 Best Long-Term Dividend Stocks to Buy in June
June 08, 2023
Build a solid investment portfolio with the best long-term dividend stocks and enjoy passive income for many years to come.
Via
InvestorPlace
Dow Stocks Like Microsoft, Apple, Disney, and Verizon Reveal Two Sides of the Market
June 06, 2023
Many well-known stocks are missing out on the market's epic 2023 rally.
Via
The Motley Fool
Check Out What Whales Are Doing With AMGN
May 23, 2023
Via
Benzinga
Amgen's Debt Overview
May 22, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
May 19, 2023
Via
Benzinga
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income
May 29, 2023
Here are three dividend-paying stocks retirees should consider for their nest egg portfolio.
Via
Talk Markets
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.
May 26, 2023
Biotech-giant Amgen aims to launch a rival.
Via
The Motley Fool
3 Safe Dividend Stocks to Beat Inflation
May 19, 2023
Look for businesses that thrive in any economic environment.
Via
The Motley Fool
3 Dogs of the Dow for High-Yield Investors
May 25, 2023
These Dogs of the Dow boast high dividend yields and will hold up well in a potential recession. Let's take a look.
Via
InvestorPlace
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
May 24, 2023
Should Pfizer and Seagen investors be worried?
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
May 23, 2023
Via
Benzinga
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
May 23, 2023
Pfizer stock surged on its diabetes news this week, but one analyst says there's a key piece missing from the story.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
May 22, 2023
Via
Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
May 22, 2023
Pfizer's diabetes drug led to faster weight loss than Novo Nordisk's Ozempic.
Via
Investor's Business Daily
Stock Market Rally Hits 2023 Highs As Big Techs Lead; Tesla, Walmart, On Holding In Focus: Weekly Review
May 19, 2023
Chips, software and AI plays were strong. But leadership remains narrow.
Via
Investor's Business Daily
The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?
May 18, 2023
The FTC suit against Amgen appears to be a clear case of regulatory overreach but what this ultimately means will take time to fully develop.
Via
Talk Markets
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.